FDA Denies Greenlighting J&J 'Phantom' Recall
The U.S. Food and Drug Administration has denied news reports claiming it knew about an alleged Johnson & Johnson Services Inc. plan in 2008 to enlist contractors to buy defective Motrin...To view the full article, register now.
Already a subscriber? Click here to view full article